The NJIIS recommendations are based on the current ACIP, AAP and AAFP schedule for routine well child immunization. The recommended schedule of immunizations for children who are immuno-compromised or have other serious medical conditions is not included in this system.






Forgot Password

Session Expired !


To All Providers - Updated 07-01-2016

Please scroll to read the entire message.

Important Announcements

  • IMPORTANT: - During June 22 to June 27, June 29 to July 1, and July 7 to July 11, the CDC will update vaccine contracts and will not accept vaccine orders. Expect modest shipping delays. You may receive a vaccine order, but not receive the Claim Shipment notice in IMODS. When the CDC system is updated, the Claim Shipment feature will be available and vaccine orders will again be delivered in a timely manner.
  • 07/01/2016 - Click Here to read the July 2016 NJ VFC Newsletter.
  • 06/23/2016 -ACIP votes down use of LAIV for 2016-2017 flu season. Click Here to read the CDC Media Statement.
  • 06/15/2016 - The New Jersey Department of Health (NJDOH) and Rutgers University-New Brunswick, with support from the Centers for Disease Control and Prevention, strongly recommend that certain Rutgers University-New Brunswick populations receive the full 3-dose series of Trumenba, with the first 2 doses received during the summer of 2016. For more information on the outbreak of meningococcal disease associated with Rutgers University,New Brunswick and the vaccination recommendations, please click here. Providers who participate in either the New Jersey Vaccines for Children (VFC) or 317- Funded Adult Program can order Trumenba for individuals recommended to be vaccinated as part of this outbreak response.
  • 4/6/16 Discontinuation of HPV2: Cervarix (HPV2) has been removed from the federal pediatric and adult contracts. Therefore, Cervarix is no longer available for order through the New Jersey VFC and 317-Funded Adult Programs.
  • Pentacel Vaccine Delay: Immunization Guidance Update The Centers for Disease Control and Prevention has updated its guidance document due to a transcription error. The initial document showed previous doses of Pentacel vaccines at 1, 2 and 4 months. This updated version shows the correct ages of 2, 4 and 6 months. Also, the HepB vaccine row is updated to reflect the recommended schedule with doses at birth, 1 to 2 months, and 6 to 18 months. Please see the Updated Pentacel Immunization Guidance here.
  • Pentacel Allocation: Sanofi Pasteur is experiencing a manufacturing delay with Pentacel vaccine. Sanofi Pasteur anticipates they will not be able meet the demand for Pentacel in the first half of 2016. The NJ VFC Program requests that you reduce orders for Pentacel to 70% of your usual usage. There are sufficient supplies of single antigen vaccines (DAPTACEL, ActHIB, and IPOL) as well as alternate combination vaccines that may used to address the gap in Pentacel supply. Click Here for more information.